Diagnostic Pipeline

Zomedica has entered into a license and supply agreement with Celsee, Inc. (“Celsee”) to develop and market Celsee’s liquid biopsy platform for application as a veterinary cancer diagnostic.

Therapeutic Pipeline

Zomedica is developing a drug pipeline of FDA Center for Veterinary Medicine (FDA-CVM) approved drugs that address the urgent and pervasive needs of clinical veterinarians. Disclosed products are identified below.